Roberto Pellicciari

This inventor holds 66 USPTO granted patents and 22 published patent applications, plus 12 CIPO patents and 22 EPO patents, primarily in Bile Acid Derivatives (CPC class C07J). Top assignees: Intercept Pharmaceuticals, Inc., Giuliani S.p.a., Tes Pharma S.r.l.. Active years: 1985-2025.

USPTO Granted Patents = 66 (Patent Applications = 22)

% Patents Active = 69.7

CIPO Patents = 12 (Patent Applications = 5)

EPO Patents = 22 (Patent Applications = 26)

Average Co-Inventor Count = 1.9

ph-index = 13

Forward Citations = 446(Granted Patents)

Forward Citations (Not Self Cited) = 270(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Milan, IT (1991 - 1994)
King of Prussia, PA (US) (2006)
Perugia, IT (1985 - 2023)

Company Filing History:

40 out of 62

Intercept Pharmaceuticals, Inc.

Alma Mater Studiorum-Universitá Di Bologna

Fondazione Istituto Italiano Di Tecnologia

patents

9. 1 out of 1,323

G.d. Searle & Company

patents

10. 1 out of 11

Istituto Europeo Di Oncologia S.r.l.

patents

11. 1 out of 40

Newron Pharmaceuticals S.p.a.

patents

12. 7 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1985-2025

Loading Chart...

Areas of Expertise:

Bile Acid Derivatives

FXR Ligands

TGR5 Modulators

Tumor Treatment

Pharmaceutical Compositions

Farnesoid X Receptor

Alpha-Amino-Beta-Carboxymuconic Acid

Fibrosis Treatment

Steroids Agonists

Thiazolyl Compounds

Isoquinolinones

Methods of Use

66 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12459914 - Compounds and compositions for the treatment of tumors (2025-11-04),

2. 12291549 - Farnesoid X receptor modulators (2025-05-06),

3. 12186317 - Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase (2025-01-07),

4. 11807659 - TGR5 modulators and methods of use thereof (2023-11-07),

5. 11345721 - TGR5 modulators and methods of use thereof (2022-05-31),

6. 11319337 - 3-desoxy derivative and pharmaceutical compositions thereof (2022-05-03),

7. 11254644 - Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase (2022-02-22),

8. 11066437 - Methods and intermediates for the preparation of bile acid derivatives (2021-07-20),

9. 11034717 - Farnesoid X receptor modulators (2021-06-15),

10. 11000532 - Farnesoid x receptor modulators (2021-05-11),

11. 10987362 - Treatment of fibrosis using FXR ligands (2021-04-27),

12. RE48286 - Steroids as agonists for FXR (2020-10-26),

13. 10815267 - 3-desoxy derivative and pharmaceutical compositions thereof (2020-10-27),

14. 10800807 - TGR5 modulators and methods of use thereof (2020-10-13),

15. 10532061 - Farnesoid X receptor modulators (2020-01-14),

Title: Roberto Pellicciari: Pioneering Innovations in Biomedical Science

Introduction:

Roberto Pellicciari, a visionary inventor hailing from Perugia, Italy, has made significant contributions to the world of patents and inventions. With a portfolio boasting 63 patents, Roberto's work has transcended boundaries in the field of biomedical science.

Latest Patents:

Among his latest patents are TGR5 modulators and methods of use thereof - innovative compounds designed to treat a spectrum of diseases, ranging from metabolic and inflammatory conditions to cancer and gastrointestinal ailments. These compounds, formulated to be TGR5 modulators, hold immense promise for revolutionizing medical treatments.

Career Highlights:

Throughout his illustrious career, Roberto Pellicciari has been associated with renowned companies such as Intercept Pharmaceuticals, Inc. His expertise and dedication have been instrumental in driving forward groundbreaking initiatives that have reshaped the landscape of biomedical research and development.

Collaborations:

Roberto has had the privilege of collaborating with esteemed professionals in the industry, including Antimo Gioiello and Aldo Roda. Together, they have synergized their talents to propel forward pioneering projects, setting new benchmarks in the realm of scientific innovation.

Conclusion:

In conclusion, Roberto Pellicciari stands as a beacon of inspiration in the world of inventions and patents, with his relentless pursuit of excellence and innovation shaping the future of scientific discovery. His remarkable contributions to the field of biomedical science underscore his unwavering commitment to advancing healthcare solutions that have the potential to transform lives globally.